Br J Ophthalmol 87:1061-1064 doi:10.1136/bjo.87.9.1061
  • World views

Diabetic retinopathy in Oman: a hospital based study

  1. R Khandekar1,
  2. J Al Lawatii2,
  3. A J Mohammed3,
  4. A Al Raisi4
  1. 1Eye and Ear Health Care, DSDC, DGHA, Ministry of Health, Oman
  2. 2Diabetes Control Program, NCD, DGHA, Ministry of Health, Oman
  3. 3Ministry of Health, Oman
  4. 4Ophthalmology Department, Al Nahdhah Hospital, Oman
  1. Correspondence to: D R Khandekar, Eye Health Care, PO Box 393, Pin 113, Muscat, Oman; rajshpp{at}
  • Accepted 3 March 2003


The magnitude of diabetic retinopathy, its determinants, and coverage of laser treatment for diabetic retinopathy among registered people with diabetes in Oman are presented. 2249 randomly selected subjects representing 5564 registered diabetics were examined. WHO recommended definitions of diabetes, retinopathy, and other related conditions were used. Physicians reported the profile of the diabetes while ophthalmologists reported ocular profile and the eye care provided to them. The prevalence of diabetic retinopathy was 14.39% (95% CI 13.46 to 15.31). Men had significantly higher rate of retinopathy than women. The retinopathy rate was higher in age groups 50–59 years and 60–69 years. The rates of background retinopathy, proliferative retinopathy, and diabetic maculopathy were 8.65%, 2.66%, and 5.12%, respectively. The rate was higher among subjects with longer duration of diabetes than those with a shorter duration. Those with an HbA1c level more than 9% had significantly higher rates of diabetic retinopathy than those with an HbA1c level less than 9%. The retinopathy rate was higher in cases with hypertension, nephropathy, and neuropathy. Of those with diabetic retinopathy who were advised to have treatment at the time of registration, only 20% were treated with laser therapy.


  • Series editors: W V Good and S Ruit